GENE ONLINE|News &
Opinion
Blog

2025-02-24|

Novel Method Combines Heart Biopsy and Device Implantation to Reduce Risk of Complications

by Mark Chiang
Share To
Newsflash | Powered by GeneOnline AI

Researchers have developed an innovative method that integrates right ventricular (RV) septal endomyocardial biopsy (EMB) with the implantation of cardiac implantable electronic devices (CIEDs), such as pacemakers or defibrillators. This new technique utilizes a single 3D curved conduction system pacing (CSP) sheath for both procedures, potentially reducing the risk of complications associated with traditional invasive methods.

Endomyocardial biopsy is a critical procedure for diagnosing various cardiac conditions but carries inherent risks due to its invasive nature. By using the same CSP sheath for both EMB and subsequent CIED implantation, this novel approach not only streamlines the process but also minimizes tissue trauma and the likelihood of complications.

This advancement represents a significant step forward in cardiac care, promising safer diagnostic and treatment options for patients requiring detailed heart tissue analysis and rhythm regulation.

Newsflash | Powered by GeneOnline AI

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Related Post
Breakthrough Discovery: Key Protein Could Enable Human Heart Regeneration
2025-02-25
LATEST
Unity Technologies Announces Unity 7 Development Roadmap at Unite Seoul
2026-07-20
Road Traffic Injuries Caused 1.34 Million Deaths and 51 Million Injuries Globally in 2023
2026-07-20
Ross Stores Expands to 2,150 Locations With 47 New Openings
2026-07-20
SRMMF Issues Formal Statement Clarifying Performance Rights Status on July 20, 2026
2026-07-20
Study Finds Collagen Peptide Supplementation May Support Bone Health in Female Runners
2026-07-20
Aspire Biopharma Signs X Games Medalist Jarryd McNeil to Promote BUZZ BOMB Line
2026-07-20
Pipistrel Introduces Voyager Aircraft With Digital Avionics for Flight Training
2026-07-20
Scroll to Top